MX2017002285A - Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas. - Google Patents

Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas.

Info

Publication number
MX2017002285A
MX2017002285A MX2017002285A MX2017002285A MX2017002285A MX 2017002285 A MX2017002285 A MX 2017002285A MX 2017002285 A MX2017002285 A MX 2017002285A MX 2017002285 A MX2017002285 A MX 2017002285A MX 2017002285 A MX2017002285 A MX 2017002285A
Authority
MX
Mexico
Prior art keywords
wrinkles
diketones
gamma
prevention
treatment
Prior art date
Application number
MX2017002285A
Other languages
English (en)
Other versions
MX368248B (es
Inventor
Kumar Kc Sunil
Hood John
F Barroga Charlene
Kibar Osman
Original Assignee
Samumed Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samumed Llc filed Critical Samumed Llc
Publication of MX2017002285A publication Critical patent/MX2017002285A/es
Publication of MX368248B publication Critical patent/MX368248B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Abstract

La presente descripción se refiere a compuestos, composiciones cosméticas o dermofarmacéuticas que comprenden los mismos y métodos para usar los compuestos para tratar, proteger y/o mejorar la condición o apariencia estética de la piel, por ejemplo, tratar, prevenir, mejorar, reducir y/o eliminar líneas de expresión y/o arrugas de la piel, o mejorar la aparición de líneas de expresión y/o arrugas de la piel comprendiendo la aplicación de los compuestos o composiciones descritos.
MX2017002285A 2014-08-20 2015-08-20 Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas. MX368248B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462039786P 2014-08-20 2014-08-20
PCT/US2015/046120 WO2016029021A1 (en) 2014-08-20 2015-08-20 Gamma-diketones for treatment and prevention of aging skin and wrinkles

Publications (2)

Publication Number Publication Date
MX2017002285A true MX2017002285A (es) 2018-01-23
MX368248B MX368248B (es) 2019-09-25

Family

ID=55351257

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002285A MX368248B (es) 2014-08-20 2015-08-20 Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas.

Country Status (25)

Country Link
US (4) US9795550B2 (es)
EP (1) EP3206686B1 (es)
JP (1) JP6766047B2 (es)
KR (1) KR102165385B1 (es)
CN (1) CN107106549B (es)
AU (1) AU2015305373B2 (es)
BR (1) BR112017003959B1 (es)
CA (1) CA2958580C (es)
CL (1) CL2017000410A1 (es)
CY (1) CY1122603T1 (es)
DK (1) DK3206686T3 (es)
ES (1) ES2762559T3 (es)
HR (1) HRP20192161T1 (es)
HU (1) HUE046741T2 (es)
IL (1) IL250663B (es)
LT (1) LT3206686T (es)
MA (1) MA40454B1 (es)
MX (1) MX368248B (es)
PL (1) PL3206686T3 (es)
PT (1) PT3206686T (es)
RS (1) RS59797B1 (es)
RU (1) RU2727039C2 (es)
SI (1) SI3206686T1 (es)
WO (1) WO2016029021A1 (es)
ZA (1) ZA201701460B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2652363T3 (es) 2010-08-18 2018-02-01 Samumed, Llc Dicetonas e hidroxicetonas como activadores de la vía de señalización de catenina
RU2680716C2 (ru) 2013-02-22 2019-02-26 СЭМЬЮМЕД, ЭлЭлСи γ-ДИКЕТОНЫ В КАЧЕСТВЕ АКТИВАТОРОВ WNT/β-КАТЕНИНОВОГО СИГНАЛЬНОГО ПУТИ
EP3206686B1 (en) 2014-08-20 2019-10-09 Samumed, LLC Gamma-diketones for treatment and prevention of aging skin and wrinkles
EP3313369B1 (en) * 2015-08-04 2020-07-15 Eupharma Pty Ltd Emollient composition
EP3393604A1 (en) * 2015-12-24 2018-10-31 Unilever NV Tyrosinase inhibitors
US20170296460A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
US10463601B1 (en) * 2016-06-17 2019-11-05 Lorita Dillon Topical cosmetic composition
WO2018081005A1 (en) * 2016-10-25 2018-05-03 Access Business Group International Llc Compositions of lithospermum erythrorhizon (gromwell root) and methods of making and using the compositions
KR20190104359A (ko) 2016-12-30 2019-09-09 프리퀀시 테라퓨틱스, 인크. 줄기/전구체 지지 세포의 자가 재생을 유도하기 위한 1h-피롤-2,5-다이온 화합물 및 이의 사용 방법
CN110769841A (zh) * 2017-06-13 2020-02-07 玫琳凯有限公司 化妆品组合物及其用于使皮肤紧致的方法
US11318179B2 (en) * 2017-06-20 2022-05-03 Jessica Kado Topical formulation for binding to dermatological cannabinoid receptors
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
EP3793508A1 (en) * 2018-05-14 2021-03-24 Johnson & Johnson Consumer Inc. Moisturizing cream and lotion
CN108813246A (zh) * 2018-05-31 2018-11-16 陕西顾森健康科技有限公司 一种易吸收防流失的胶原蛋白肽抗衰组合物及其制备工艺
US10980851B2 (en) * 2018-06-08 2021-04-20 The Procter & Gamble Company Topical skincare compositions comprising Centella asiatica selected triterpenes
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
JP2021533788A (ja) 2018-08-17 2021-12-09 フリークエンシー セラピューティクス インコーポレイテッド Ｊａｇ−１を上方制御することにより有毛細胞を生成するための組成物及び方法
KR101938877B1 (ko) * 2018-08-20 2019-01-16 안디바 주식회사 수딩크림 조성물 및 그의 제조방법
CN109394570A (zh) * 2018-11-08 2019-03-01 杭州百芮生物科技有限公司 一种超分子水杨酸复合凝胶及其制备方法
KR102021014B1 (ko) * 2018-11-21 2019-09-16 신민지 가슴 크림 제조방법 및 이에 의해 제조된 가슴 크림
DE102018131724A1 (de) * 2018-12-11 2020-06-18 Wellstar Gmbh & Co. Kg Zusammensetzung und Verwendung der Zusammensetzung als Anti-Aging-Mittel
KR101987099B1 (ko) * 2018-12-19 2019-06-10 주식회사 메디셀 피부온도 감응형 기능성 하이드로겔 조성물을 이용한 팔뚝 붓기완화용 패치 및 그 제조방법
KR102031885B1 (ko) * 2019-01-08 2019-10-15 안디바 주식회사 마카 추출물을 함유한 수딩크림 조성물
EP3930740A4 (en) * 2019-02-25 2022-12-21 Topix Pharmaceuticals, Inc. METHODS, COMPOSITIONS, FILMS FOR THERAPEUTIC SKIN TREATMENTS
CN109820802A (zh) * 2019-04-11 2019-05-31 冯江 一种亮颜润肤精华液及其制备方法
CN109925248B (zh) * 2019-04-28 2021-10-19 青岛科技大学 一种含有根皮素、三七总皂苷抗皮肤光老化作用的护肤组合物
FR3097558B1 (fr) * 2019-06-24 2021-06-25 Oreal Méthode de diagnostic d’un vieillissement prématuré de la peau
US11633368B2 (en) 2019-09-03 2023-04-25 Milton D. Moore Enhanced moisturizing lotion compositions
CN110711161A (zh) * 2019-11-03 2020-01-21 广州悦荟化妆品有限公司 一种免洗型的舒敏修护精华面膜
KR102369744B1 (ko) * 2019-12-24 2022-03-03 경희대학교 산학협력단 부들레야 다비디 추출물을 포함하는 항염증용 조성물
US20210251852A1 (en) * 2020-02-14 2021-08-19 Tiwona Ross Aloe Mint Scalp Wipes
CN111297736A (zh) * 2020-03-18 2020-06-19 苏州工业园区黛宜菲化妆品有限公司 一种具有修护皮脂膜作用的修颜油
CN111388376B (zh) * 2020-04-20 2022-06-21 广西诗琳茉莉生物科技集团有限公司 一种茉莉草本抗敏舒缓面膜及其制备方法
US11213473B1 (en) * 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition
KR102233707B1 (ko) * 2021-01-06 2021-03-29 김현숙 천연 추출물 및 천연 가루를 포함하는 화장료 조성물
US20220241305A1 (en) * 2021-01-29 2022-08-04 ChromaDex Inc. Ethyl cellulose based coatings for microencapsulation of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives
CN112870108A (zh) * 2021-02-07 2021-06-01 上海百雀羚生物科技有限公司 一种具有抗衰老、保湿功效的组合物及其制备方法和应用
US11642305B2 (en) 2021-06-03 2023-05-09 Melissa Kadzai Composition for a skin and hair product
CN113876641A (zh) * 2021-11-05 2022-01-04 上海新高姿化妆品有限公司 一种具有抗皱紧致功效的化妆品组合物及其应用
US11484489B1 (en) * 2021-12-08 2022-11-01 Codex Beauty Corporation Skin care compositions and methods for regulating sebum production
CN113956244B (zh) * 2021-12-21 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种用于皮肤复新的肌肽衍生物及其用途
US20230240960A1 (en) * 2022-01-07 2023-08-03 Revela, Inc Compositions, formulations, and methods for skin treatment
WO2023141410A1 (en) * 2022-01-18 2023-07-27 IC-MedTech Corp. Bicyclic quinones, pharmaceutical compositions, and therapeutic applications
CN114432207B (zh) * 2022-03-09 2023-06-16 上海柒色生物科技有限公司 一种长效保湿修复组合物、修复霜及其制备方法
CN115804736B (zh) * 2022-12-14 2024-04-26 广州臻颜化妆品有限公司 一种多效润唇膏及其制备方法
KR102597707B1 (ko) * 2023-09-07 2023-11-03 (주)스타팜텍 얼굴 주름 개선 및 미백 효과를 가지는 기능성 화장품 조성물
CN117653563A (zh) * 2023-12-13 2024-03-08 奥俐莱雅（广东）家化科技有限公司 一种高透皮性的重组胶原蛋白肽及其制备工艺和应用

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3040054A (en) 1960-08-03 1962-06-19 Olin Mathieson 2, 2'-(1, 4-diaminotetramethylene) bis(4-thiazolecarboxylic acid), salts and process
US3855675A (en) 1971-05-25 1974-12-24 Squibb & Sons Inc 1-(2-furanylmethyl)-1h-pyrazolo(3,4-b)pyridine-5-methanones
US4014889A (en) 1972-12-20 1977-03-29 Bayer Aktiengesellschaft Process for preparing ketones
US4032526A (en) 1975-10-02 1977-06-28 American Cyanamid Company 1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
US4164559A (en) 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
DE2808070A1 (de) 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
DE3331692A1 (de) 1983-09-02 1985-03-28 Basf Ag, 6700 Ludwigshafen 3-phenyl-4-methoxycarbonylpyrazole, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
EP0230110A1 (en) 1985-11-30 1987-07-29 FISONS plc Pharmacologically active pyrrole and pyrazole derivatives
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
WO1990011366A1 (en) 1989-03-28 1990-10-04 Genetics Institute, Inc. Osteoinductive compositions
WO1988003805A1 (en) 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
FR2613360B1 (fr) * 1987-04-03 1989-06-09 Oreal Nouveaux derives aromatiques d'acide butyrique, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique
NZ227287A (en) 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments
AU626881B2 (en) 1988-07-14 1992-08-13 F. Hoffmann-La Roche Ag Benzofused heterocyclics used as pharmaceuticals
IL91418A (en) 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
EP0365089A3 (en) 1988-10-18 1991-06-05 Merck & Co. Inc. 2-aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl) tetrahydrothiophen and analogs
ES2073661T3 (es) 1990-04-27 1995-08-16 Duphar Int Res Metodo para la isomerizacion fotoquimica de compuestos organicos bajo la influencia de un fotosensibilizador.
DE4104931A1 (de) 1991-02-18 1992-08-20 Hoechst Ag Verfahren zur herstellung substituierter indene
JPH05170764A (ja) 1991-12-24 1993-07-09 Sumitomo Pharmaceut Co Ltd 新規なヒドロキシカルコン誘導体
GB9203806D0 (en) 1992-02-21 1992-04-08 Unilever Plc Sunscreen agents
DK57892D0 (da) 1992-05-01 1992-05-01 Nkt Res Center As Fremgangsmaade til fremstilling af 1,4-bis-aryl-butan-1,4-dioner og poly(arylen-butan-1,4-dioner)
EP0738705B1 (en) 1994-10-07 2001-05-09 Meiji Seika Kabushiki Kaisha Gamma-diketone compound having platelet aggregation inhibiting effect
WO1996021665A1 (en) 1995-01-13 1996-07-18 Board Of Regents, The University Of Texas System Turcasarins, novel expanded porphyrins, and uses thereof
US5668148A (en) 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
US5585118A (en) 1995-06-02 1996-12-17 Brigham And Women's Hospital Choline in the treatment of bipolar disorder
US5668165A (en) 1995-06-07 1997-09-16 Scriptgen Pharmaceuticals, Inc. Small molecule inhibition of RNA/ligand binding
JP3964478B2 (ja) 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
KR19990082639A (ko) 1996-02-19 1999-11-25 미즈노 마사루 당뇨병 치료제
ES2205240T3 (es) 1996-06-03 2004-05-01 Purdue Research Foundation Agentes anti-tumorales de selenofenos.
US6620804B2 (en) 1996-06-03 2003-09-16 Purdue Research Foundation Selenophene anti-tumor agents
US6440102B1 (en) 1998-07-23 2002-08-27 Durect Corporation Fluid transfer and diagnostic system for treating the inner ear
EP1104418A2 (en) 1998-08-11 2001-06-06 Nihon Bayer Agrochem K.K. Nematicidal pyrazoles
AU1707700A (en) 1998-10-29 2000-05-22 Bristol-Myers Squibb Company Novel inhibitors of impdh enzyme
DE19853299C2 (de) 1998-11-19 2003-04-03 Thomas Lenarz Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
US6120484A (en) 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same
EP1196384A4 (en) 1999-06-25 2002-10-23 Merck & Co Inc 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS
EP1067195B1 (de) 1999-07-09 2006-09-20 Forschungszentrum Jülich Gmbh Verfahren zur Reduktion von Ketogruppen enthaltende Verbindungen
ES2251392T3 (es) 1999-07-13 2006-05-01 Lonza Ag Procedimiento para preparar 2-amino-4-(4-fluorofenil)-6-alquilpirimidina-5-carboxilatos.
DE60019505T2 (de) 1999-08-06 2005-09-15 Ciba Speciality Chemicals Holding Inc. Mikrobizide Wirksubstanzen
AUPQ288499A0 (en) 1999-09-16 1999-10-07 Biota Scientific Management Pty Ltd Antiviral agents
AU7824900A (en) 1999-10-07 2001-04-23 Eli Lilly And Company Compounds and methods for inhibiting mrp1
US6268375B1 (en) * 1999-12-29 2001-07-31 Research Triangle Institute 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
JP2001294581A (ja) 2000-04-12 2001-10-23 Nippon Bayer Agrochem Co Ltd イソチアゾール誘導体
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
PL360294A1 (en) 2000-07-05 2004-09-06 Yamanouchi Pharmaceutical Co.Ltd. Propane-1,3-dione derivatives
US20020022040A1 (en) 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
DE10059749A1 (de) 2000-12-01 2002-06-20 Henkel Kgaa Fixierung von Wirkstoffen an fasrigen Materialien
US7012075B2 (en) 2001-03-02 2006-03-14 Merck & Co., Inc. Cathepsin cysteine protease inhibitors
JP4160401B2 (ja) * 2001-03-29 2008-10-01 バーテックス ファーマシューティカルズ インコーポレイテッド Ｃ−ｊｕｎｎ末端キナーゼ（ｊｎｋ）および他のタンパク質キナーゼのインヒビター
EP1373263B1 (en) * 2001-04-05 2004-10-27 Torrent Pharmaceuticals Ltd Heterocyclic compounds for aging-related and diabetic vascular complications
ATE433751T1 (de) 2001-04-30 2009-07-15 Vertex Pharma Inhibitoren von gsk-3 und kristallstrukturen von gsk-3beta-protein und -proteinkomplexen
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
WO2003016266A1 (en) 2001-08-16 2003-02-27 Japan Tobacco Inc. β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF
US6648873B2 (en) 2001-09-21 2003-11-18 Durect Corp. Aural catheter system including anchor balloon and balloon inflation device
KR20050035142A (ko) 2001-10-11 2005-04-15 카네카 코포레이션 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법
CN1155590C (zh) 2002-04-12 2004-06-30 中国药科大学 具有抗肿瘤活性的色酮类化合物及其开环产物与制备方法
US7166619B2 (en) 2002-08-14 2007-01-23 Ppd Discovery , Inc. Prenylation inhibitors and methods of their synthesis and use
US20040266732A1 (en) 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
FR2849598B1 (fr) 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
US20040224003A1 (en) 2003-02-07 2004-11-11 Schultz Robert K. Drug formulations for coating medical devices
DE602004012083T2 (de) 2003-04-15 2009-04-23 Astrazeneca Ab Neue Verbindungen, die als Verstärker von Glutamatrezeptoren dienen
JP4845730B2 (ja) * 2003-07-17 2011-12-28 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US20050175562A1 (en) 2004-01-05 2005-08-11 Anke Hadasch Skin makeup composition
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
US20060276536A1 (en) 2004-02-12 2006-12-07 Vander Jagt David L Cancer treatment using curcumin derivatives
US20070185152A1 (en) * 2004-03-02 2007-08-09 Smithkline Beecham Corporation Inhibitors of akt activity
US7825278B2 (en) 2004-05-06 2010-11-02 The Regents Of The University Of California Substituted enaminones, their derivatives and uses thereof
CN1964950A (zh) 2004-06-04 2007-05-16 安斯泰来制药有限公司 丙烷－1,3－二酮衍生物或其盐
DE102004029309A1 (de) 2004-06-17 2005-12-29 Bayer Cropscience Gmbh Pyridinylisoxazole und ihre Verwendung als Herbizide
EP2298291A3 (en) 2004-06-18 2011-08-03 Agennix USA Inc. Kinase inhibitors for treating cancers
JP2008517584A (ja) 2004-08-16 2008-05-29 アディポジェン ファーマシューティカルズ ピーティーワイ リミテッド 代謝調節薬剤およびそのための使用
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
JP2008094720A (ja) 2005-01-20 2008-04-24 Astellas Pharma Inc キノロン誘導体のプロドラッグ又はその塩
WO2006079055A2 (en) 2005-01-24 2006-07-27 Neurosystec Corporation Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
AU2006211159A1 (en) 2005-02-01 2006-08-10 Wyeth Amino-pyridines as inhibitors of beta-secretase
CA2603185C (en) 2005-03-31 2011-07-26 Astellas Pharma Inc. Propane-1,3-dione derivative or salt thereof
WO2007000998A1 (ja) 2005-06-27 2007-01-04 Tohoku University ビス(アリールメチリデン)アセトン化合物、抗癌剤、発癌予防剤、Ki-Ras、ErbB2、c-Myc及びCyclinD1の発現抑制剤、β-カテニン分解剤並びにp53の発現増強剤
DE102005031580A1 (de) 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituierte Sulfolanylpyrazole und ihre Verwendung
AU2006275514B2 (en) 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
WO2007051314A1 (en) 2005-11-07 2007-05-10 American Diagnostica Inc. Curcuminoid compounds for inhibiting plasminogen activator inhibitor-1
CA2629461C (en) 2005-11-10 2016-01-12 Anita Melikian Substituted quinolones and methods of use
WO2007103584A2 (en) 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
KR20080109918A (ko) 2006-04-11 2008-12-17 버텍스 파마슈티칼스 인코포레이티드 전압 개폐 나트륨 채널의 억제제로서 유용한 조성물
JP2008007428A (ja) 2006-06-27 2008-01-17 Showa Denko Kk 皮膚外用シワ防止剤
JPWO2008020625A1 (ja) 2006-08-17 2010-01-07 国立大学法人金沢大学 ジベンゾイルメタン系化合物とそれを有効成分とする医薬組成物
CN101505721B (zh) 2006-08-30 2013-12-18 株式会社益力多本社 皱纹形成抑制剂
US7875603B2 (en) 2006-09-21 2011-01-25 Nova Southeastern University Specific inhibitors for vascular endothelial growth factor receptors
JP5207341B2 (ja) 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
JP5231829B2 (ja) 2007-02-15 2013-07-10 石原産業株式会社 ピリジル−トリアゾロピリミジン誘導体又はその塩、それらを含有する有害生物防除剤並びにそれらの製造方法
WO2008118626A2 (en) 2007-03-08 2008-10-02 Burnham Institute For Medical Research Inhibitors of jnk and methods for identifying inhibitors of jnk
JP5309318B2 (ja) 2007-03-09 2013-10-09 国立大学法人 岡山大学 エステル、カルボン酸及びアミドの製造方法
EP2155742A1 (en) 2007-04-18 2010-02-24 AstraZeneca AB 5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer
KR101404398B1 (ko) 2007-06-20 2014-06-09 (주)뉴트리 주름개선 화장료 조성물
EP2209491B1 (en) 2007-11-02 2015-10-28 Novartis AG Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
EA201000673A1 (ru) 2007-11-05 2011-04-29 Новартис Аг СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ИЗМЕРЕНИЯ АКТИВАЦИИ Wnt И ДЛЯ ЛЕЧЕНИЯ Wnt-ОПОСРЕДОВАННЫХ РАКОВЫХ ЗАБОЛЕВАНИЙ
EP2240276B1 (en) 2007-12-06 2020-12-02 Centre National de la Recherche Scientifique (CNRS) Iron and copper catalytic systems for cross-coupling reactions
JP2009179619A (ja) 2008-02-01 2009-08-13 Toyo Ink Mfg Co Ltd 新規オキシムエステル化合物およびそれを含んでなるラジカル重合開始剤および重合性組成物
MX2010009385A (es) 2008-02-27 2010-12-21 Schering Plough Healthcare Fotoestabilidad mejorada de composiciones para proteccion solar que contienen avobenzona.
WO2009129267A2 (en) 2008-04-14 2009-10-22 The Board Of Regents Of The University Of Texas System Small molecule inhibitors of the pleckstrin homology domain and methods for using same
KR101538822B1 (ko) 2008-05-08 2015-07-22 노바 사우쓰이스턴 유니버시티 혈관 내피 성장 인자 수용체에 대한 특이적 억제제
ES2622148T3 (es) 2008-11-05 2017-07-05 University Of Southern California Moduladores de Moléculas Pequeñas de Regulación Epigenética y sus Aplicaciones Terapéuticas
US20130039998A1 (en) 2008-12-24 2013-02-14 University Of Washington Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder
JP5246715B2 (ja) 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
UA103918C2 (en) 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
WO2011009826A2 (en) * 2009-07-21 2011-01-27 ADAMED Sp.z o.o. Novel chalcone derivatives with cytotoxic activity
ES2652363T3 (es) 2010-08-18 2018-02-01 Samumed, Llc Dicetonas e hidroxicetonas como activadores de la vía de señalización de catenina
KR101784940B1 (ko) 2010-08-31 2017-10-12 (주)아모레퍼시픽 피부 탄력 개선용 화장료 조성물
CA2825599C (en) 2011-02-01 2021-07-13 The Board Of Trustees Of The University Of Illinois 4-methyl-n-hydroxybenzamide compounds as histone deacetylase (hdac) inhibitors
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
US8871748B2 (en) * 2011-09-07 2014-10-28 Island Kinetics Inc. Retinal cyclodextrin acetals and hemiacetals for treating skin complexion disorder
US9668691B2 (en) 2011-09-22 2017-06-06 Lvmh Recherche Method to measure skin elasticity and firmness
US9290427B2 (en) * 2012-01-30 2016-03-22 Universiteit Gent Anti-invasive compounds
US20130302381A1 (en) 2012-05-09 2013-11-14 Cook Medical Technologies Llc Implantable Medical Devices Including a Water-Insoluble Therapeutic Agent
US8865700B2 (en) * 2012-12-20 2014-10-21 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin
SI2958944T1 (sl) 2013-02-22 2019-08-30 Abb Vie Stemcentrx Llc Konjugati protiDLL3-protitelo-PBD in njihove uporabe
RU2680716C2 (ru) 2013-02-22 2019-02-26 СЭМЬЮМЕД, ЭлЭлСи γ-ДИКЕТОНЫ В КАЧЕСТВЕ АКТИВАТОРОВ WNT/β-КАТЕНИНОВОГО СИГНАЛЬНОГО ПУТИ
DK2958921T3 (da) 2013-02-22 2017-11-06 Pfizer Pyrrolo[2,3-D]pyrimidin-derivater som hæmmere af Janus kinaser (JAK)
KR102230628B1 (ko) 2013-02-22 2021-03-22 하. 룬드벡 아크티에셀스카브 보르티옥세틴 제조 방법
EP3206686B1 (en) 2014-08-20 2019-10-09 Samumed, LLC Gamma-diketones for treatment and prevention of aging skin and wrinkles

Also Published As

Publication number Publication date
AU2015305373B2 (en) 2020-12-10
PT3206686T (pt) 2020-01-06
EP3206686B1 (en) 2019-10-09
JP6766047B2 (ja) 2020-10-07
RS59797B1 (sr) 2020-02-28
CN107106549A (zh) 2017-08-29
SI3206686T1 (sl) 2020-03-31
EP3206686A1 (en) 2017-08-23
KR102165385B1 (ko) 2020-10-15
RU2727039C2 (ru) 2020-07-17
BR112017003959A2 (pt) 2018-12-18
US20180193244A1 (en) 2018-07-12
RU2017108750A (ru) 2018-09-23
CY1122603T1 (el) 2021-03-12
CN107106549B (zh) 2020-06-16
US10434052B2 (en) 2019-10-08
WO2016029021A1 (en) 2016-02-25
AU2015305373A1 (en) 2017-03-16
ES2762559T3 (es) 2020-05-25
HRP20192161T1 (hr) 2020-02-21
US20160206540A1 (en) 2016-07-21
EP3206686A4 (en) 2018-04-11
IL250663A0 (en) 2017-04-30
BR112017003959B1 (pt) 2022-08-02
US9795550B2 (en) 2017-10-24
US11077046B2 (en) 2021-08-03
US20200222295A1 (en) 2020-07-16
MX368248B (es) 2019-09-25
US11839679B2 (en) 2023-12-12
HUE046741T2 (hu) 2020-03-30
IL250663B (en) 2020-09-30
KR20170066342A (ko) 2017-06-14
JP2017525767A (ja) 2017-09-07
ZA201701460B (en) 2023-12-20
US20220087917A1 (en) 2022-03-24
CA2958580A1 (en) 2016-02-25
CL2017000410A1 (es) 2017-10-30
MA40454B1 (fr) 2020-01-31
CA2958580C (en) 2023-10-24
DK3206686T3 (da) 2019-12-16
LT3206686T (lt) 2020-01-10
RU2017108750A3 (es) 2019-04-02
PL3206686T3 (pl) 2020-04-30

Similar Documents

Publication Publication Date Title
ZA201701460B (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles
MY194586A (en) Anti-garp antibody
MX2012013787A (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
EP3352755A4 (en) Novel Compositions and Methods for the Treatment and Prevention of Skin Diseases
EP3405172A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN AGING
MX2017002388A (es) Composiciones para fibras de queratina.
EP3280390A4 (en) Method of cosmetic treatment to protect the skin from pollution and improve skin regeneration
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
EP3713583A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
WO2016149659A3 (en) Antisense-induced exon exclusion in myostatin
MX2015013883A (es) Composicion que comprende ciclodextrina como agente de proteccion de radiacion uv e ir.
IL272121A (en) Preparation and methods for the treatment of myopia
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
EP3536701A4 (en) NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR INHIBITION OF AGING OF THE SKIN OR THE FORMATION OF WRINKLES CONTAINING IT
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
EP3719032A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF HAIR LOSS
MX2018015431A (es) Composicion cosmetica anti-signos, uso de la composicion, metodo de tratamiento anti-signos y dispositivo aplicador.
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
WO2014144017A3 (en) Compositions and methods for treating conditions that affect epidermis
MX2019004179A (es) Composiciones de apilimod y metodos para utilizar las mismas en el tratamiento de la enfermedad de alzheimer.
MX2018015433A (es) Composicion cosmetica anti-signos, uso de la composicion y metodo de tratamiento anti-signos.
WO2012170664A3 (en) Methods of cancer treatment and prevention through the modulation of sirt4 activity
EP3501494A4 (en) ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THIS COMPOSITION AND ANTI-WRINKLE TREATMENT METHOD

Legal Events

Date Code Title Description
FG Grant or registration